Chengdu Easton Biopharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 4.48% vs -14.37% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -18.91% vs -36.12% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "326.30",
          "val2": "312.30",
          "chgp": "4.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.40",
          "val2": "43.20",
          "chgp": "-29.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.90",
          "val2": "3.80",
          "chgp": "55.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "43.30",
          "val2": "53.40",
          "chgp": "-18.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "93.30%",
          "val2": "54.90%",
          "chgp": "3.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1.25% vs 20.78% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 14.86% vs 5.12% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,319.60",
          "val2": "1,336.30",
          "chgp": "-1.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "275.50",
          "val2": "252.60",
          "chgp": "9.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "3.90",
          "chgp": "-30.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "17.10",
          "val2": "14.90",
          "chgp": "14.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "273.60",
          "val2": "238.20",
          "chgp": "14.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "137.50%",
          "val2": "125.80%",
          "chgp": "1.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

326.30

312.30

4.48%

Operating Profit (PBDIT) excl Other Income

30.40

43.20

-29.63%

Interest

0.60

0.60

Exceptional Items

5.90

3.80

55.26%

Consolidate Net Profit

43.30

53.40

-18.91%

Operating Profit Margin (Excl OI)

93.30%

54.90%

3.84%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 4.48% vs -14.37% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -18.91% vs -36.12% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,319.60

1,336.30

-1.25%

Operating Profit (PBDIT) excl Other Income

275.50

252.60

9.07%

Interest

2.70

3.90

-30.77%

Exceptional Items

17.10

14.90

14.77%

Consolidate Net Profit

273.60

238.20

14.86%

Operating Profit Margin (Excl OI)

137.50%

125.80%

1.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -1.25% vs 20.78% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 14.86% vs 5.12% in Dec 2024

All Annual Results